Ignite Creation Date:
2024-05-06 @ 1:18 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01772797
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2013-01-17
Brief Title:
Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-17
First Submit QC Date:
January 17 2013
Study First Post Date:
2013-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL